Shares of Oxford Cannabinoid Technologies Holdings Plc (LON:OCTP – Get Free Report) were down 4.2% during trading on Friday . The stock traded as low as GBX 0.12 ($0.00) and last traded at GBX 0.12 ($0.00). Approximately 11,402,242 shares traded hands during trading, an increase of 22% from the average daily volume of 9,326,041 shares. The stock had previously closed at GBX 0.12 ($0.00).
Oxford Cannabinoid Technologies Stock Performance
The firm’s 50 day moving average price is GBX 0.12 and its two-hundred day moving average price is GBX 0.17. The company has a market cap of £1.25 million, a P/E ratio of -53.10 and a beta of 0.82.
About Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions.
Further Reading
- Five stocks we like better than Oxford Cannabinoid Technologies
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Top-Performing Non-Leveraged ETFs This Year
- Basic Materials Stocks Investing
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Oxford Cannabinoid Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Cannabinoid Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
